Authors’ conclusions
Exercise can be regarded as beneficial for individuals with cancer-related fatigue during and post cancer therapy. Further research is
required to determine the optimal type, intensity and timing of an exercise intervention.
P L A I N L A N G U A G E S U M M A R Y
The effect of exercise on fatigue associated with cancer
Fatigue is now recognised as a side-effect of cancer and its treatment. In the past people with cancer were encouraged to rest if they
felt fatigued. It is important that individuals with cancer receive appropriate support and advice to help them cope with any adverse-
effects. Physical exercise has been suggested as helpful in reducing the fatigue that is associated with cancer. A number of studies have
been carried out to investigate the effects of exercise both during and after treatment. The current review was carried out to evaluate the
effect of physical exercise on fatigue related to cancer. Twenty-eight studies were included in the review. Results suggest that physical
exercise can help to reduce fatigue both during and after treatment for cancer. However, the evidence is not sufficient to demonstrate
the best type or intensity of exercise for reducing the symptom of fatigue.
B A C K G R O U N D
As a result of improved therapy, people with cancer are surviving
longer and having to deal with the long-term consequences of the
disease and its therapy. There are thus an increasing number of
individuals who need supportive care to enhance their quality of
life (Lucia 2003). This has lead to an increasing recognition of the
symptoms associated with cancer and cancer management with
relief of these symptoms emerging as an important dimension of
cancer patient care.
Cancer-related fatigue (CRF) is an abstract, multidimensional sub-
jective experience, affecting 70 to 100% of the cancer patient pop-
ulation (Mock 2001b). It has a profound effect on the whole per-
son, physically, emotionally and mentally (Ahlberg 2003), and can
persist for months or even years following completion of treat-
ment. It can have a phenomenal impact on a patient’s life, interfer-
ing with daily activities (Curt 2000) and also may potentially have
devastating social and economic consequences (Fletchner 2002).
It can hinder a patient’s chance of remission or even cure, owing
to the effect it can have on the desire to continue with treatment
(Morrow 2001).
In spite of the prevalence and impact of CRF there is limited data
available with regards to the precise aetiology, pattern over time
and exacerbating and relieving factors (Fletchner 2002), thus com-
plicating the development of effective management interventions
(Dimeo 2002). The aetiology of CRF remains to be fully estab-
lished and a number of causes have been suggested, such as, the
effect of tumour and cancer treatment, comorbid medical condi-
tions including anaemia, hypothyroidism, cytokines, sleep prob-
lems, psychological factors such as anxiety and depression and loss
of functional status (Lucia 2003;Wagner 2004;Mustian 2007).
The cause of CRF may also differ between individuals as well as
according to the phase of the disease and the type of treatment
received (Ryan 2007).
The National Comprehensive Cancer Network (NCCN 2005)
has developed guidelines for the management of CRF. Initially
any treatable factors that may cause fatigue should be identified
and treated. The panel identified seven factors; pain, emotional
distress, sleep disturbance, anaemia, nutrition, activity level and
comorbidities. If the patient does not have any treatable contribut-
ing factors or CRF persists, then additional treatment is recom-
mended depending on the patient’s clinical status. This incorpo-
rates education and counseling, general strategies for the manage-
ment of fatigue, pharmacological and non-pharmacological inter-
ventions. In line with these guidelines the role of non-pharma-
cological interventions in the management of CRF is supported
by Mustian 2007 and colleagues who have identified psychosocial
therapies, physical exercise, and a range of other interventions as
potentially beneficial. Activity enhancement is also recommended
by the NCCN as one of the non-pharmacological interventions at
all stages of the disease process: during active treatment, disease-
free patients on long-term follow-up and at the end of life (NCCN
2005).
The physical dimension of CRF is likely to have an organic aeti-
ology (Dimeo 2001). The effect of treatment and a reduction in
physical activity can lead to a reduction in physical performance
(NCCN 2005). Thus, the patient requires an increased effort to
2Exercise for the management of cancer-related fatigue in adults (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.